ResMed (NYSE:RMD) Stock, Unusual Options

ResMed

Overview

News

Earnings

Options

Dividends

Analyst Ratings

Insider Trades

Short Interest

Government Trades

Stock Report

ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea combined with ageing populations and increasing prevalence of obesity is resulting in a structurally growing market. The company earns roughly two thirds of its revenue in the Americas and the balance across other regions dominated by Europe, Japan and Australia. Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor and payer in the out-of-hospital setting.

Comments

ResMed Unusual Options